Elicio Therapeutics Inc (ELTX)
9.15
+0.05
(+0.55%)
USD |
NASDAQ |
Apr 30, 16:00
9.15
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2022 | 23.90M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
23.90M
Minimum
Sep 2022
23.90M
Maximum
Sep 2022
23.90M
Average
23.90M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
| Immuneering Corp | 28.44M |
| Oragenics Inc | 0.2839M |
| Outlook Therapeutics Inc | 5.120M |
| Amylyx Pharmaceuticals Inc | 3.543M |
| NovaBay Pharmaceuticals Inc | 1.91M |